BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 20418782)

  • 1. Inverse relationship between cerebrovascular lesions and severity of lewy body pathology in patients with lewy body diseases.
    Ghebremedhin E; Rosenberger A; Rüb U; Vuksic M; Berhe T; Bickeböller H; de Vos RA; Thal DR; Deller T
    J Neuropathol Exp Neurol; 2010 May; 69(5):442-8. PubMed ID: 20418782
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence and impact of vascular and Alzheimer pathologies in Lewy body disease.
    Jellinger KA; Attems J
    Acta Neuropathol; 2008 Apr; 115(4):427-36. PubMed ID: 18273624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A critical reappraisal of current staging of Lewy-related pathology in human brain.
    Jellinger KA
    Acta Neuropathol; 2008 Jul; 116(1):1-16. PubMed ID: 18592254
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distribution of cerebral amyloid deposition and its relevance to clinical phenotype in Lewy body dementia.
    Fujishiro H; Iseki E; Higashi S; Kasanuki K; Murayama N; Togo T; Katsuse O; Uchikado H; Aoki N; Kosaka K; Arai H; Sato K
    Neurosci Lett; 2010 Dec; 486(1):19-23. PubMed ID: 20851165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lewy body-related alpha-synucleinopathy in the aged human brain.
    Jellinger KA
    J Neural Transm (Vienna); 2004 Oct; 111(10-11):1219-35. PubMed ID: 15480835
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence and impact of cerebrovascular lesions in Alzheimer and lewy body diseases.
    Jellinger KA
    Neurodegener Dis; 2010; 7(1-3):112-5. PubMed ID: 20173339
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of vascular lesions in dementia with Lewy bodies. A postmortem study.
    Jellinger KA
    J Neural Transm (Vienna); 2003 Jul; 110(7):771-8. PubMed ID: 12811637
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Morphological characteristics differentiate dementia with Lewy bodies from Parkinson disease with and without dementia.
    Jellinger KA
    J Neural Transm (Vienna); 2023 Jul; 130(7):891-904. PubMed ID: 37306790
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cognitive status correlates with neuropathologic stage in Parkinson disease.
    Braak H; Rüb U; Jansen Steur EN; Del Tredici K; de Vos RA
    Neurology; 2005 Apr; 64(8):1404-10. PubMed ID: 15851731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathological entity of dementia with Lewy bodies and its differentiation from Alzheimer's disease.
    Marui W; Iseki E; Kato M; Akatsu H; Kosaka K
    Acta Neuropathol; 2004 Aug; 108(2):121-8. PubMed ID: 15235805
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Age-associated prevalence and risk factors of Lewy body pathology in a general population: the Hisayama study.
    Wakisaka Y; Furuta A; Tanizaki Y; Kiyohara Y; Iida M; Iwaki T
    Acta Neuropathol; 2003 Oct; 106(4):374-82. PubMed ID: 12904992
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alpha-synuclein pathology in Parkinson's and Alzheimer's disease brain: incidence and topographic distribution--a pilot study.
    Jellinger KA
    Acta Neuropathol; 2003 Sep; 106(3):191-201. PubMed ID: 12845452
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gray matter atrophy in Parkinson disease with dementia and dementia with Lewy bodies.
    Beyer MK; Larsen JP; Aarsland D
    Neurology; 2007 Aug; 69(8):747-54. PubMed ID: 17709706
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlations of CSF tau and amyloid levels with Alzheimer pathology in neuropathologically verified dementia with Lewy bodies.
    Brunnström H; Hansson O; Zetterberg H; Londos E; Englund E
    Int J Geriatr Psychiatry; 2013 Jul; 28(7):738-44. PubMed ID: 22911491
    [TBL] [Abstract][Full Text] [Related]  

  • 15. APOE, vascular pathology, and the AD brain.
    Yip AG; McKee AC; Green RC; Wells J; Young H; Cupples LA; Farrer LA
    Neurology; 2005 Jul; 65(2):259-65. PubMed ID: 16043796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mild cognitive impairment is related to Alzheimer disease pathology and cerebral infarctions.
    Bennett DA; Schneider JA; Bienias JL; Evans DA; Wilson RS
    Neurology; 2005 Mar; 64(5):834-41. PubMed ID: 15753419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of cerebrovascular lesions in patients with Lewy body dementia: a neuropathological study.
    De Reuck J; Deramecourt V; Cordonnier C; Leys D; Pasquier F; Maurage CA
    Clin Neurol Neurosurg; 2013 Jul; 115(7):1094-7. PubMed ID: 23237637
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Temporal lobe atrophy on MRI in Parkinson disease with dementia: a comparison with Alzheimer disease and dementia with Lewy bodies.
    Tam CW; Burton EJ; McKeith IG; Burn DJ; O'Brien JT
    Neurology; 2005 Mar; 64(5):861-5. PubMed ID: 15753423
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does striatal pathology distinguish Parkinson disease with dementia and dementia with Lewy bodies?
    Jellinger KA; Attems J
    Acta Neuropathol; 2006 Sep; 112(3):253-60. PubMed ID: 16804711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of cerebrovascular lesions in Alzheimer disease--a comparative autopsy study.
    Jellinger KA; Mitter-Ferstl E
    J Neurol; 2003 Sep; 250(9):1050-5. PubMed ID: 14504965
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.